vs
Side-by-side financial comparison of ACNB CORP (ACNB) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.
ACNB CORP is the larger business by last-quarter revenue ($47.2M vs $38.3M, roughly 1.2× ImmunityBio, Inc.). ACNB CORP runs the higher net margin — 22.9% vs -161.8%, a 184.7% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 42.2%). ACNB CORP produced more free cash flow last quarter ($52.6M vs $-71.3M).
ACNB Corp is a US-based financial holding company headquartered in Pennsylvania. It provides a full suite of financial solutions including retail and commercial banking, wealth management, trust services, and property & casualty insurance products. Its core market covers local communities, individual consumers, and small-to-medium enterprises across south-central Pennsylvania and northern Maryland.
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
ACNB vs IBRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.2M | $38.3M |
| Net Profit | $10.8M | $-61.9M |
| Gross Margin | — | 99.0% |
| Operating Margin | 27.9% | -169.0% |
| Net Margin | 22.9% | -161.8% |
| Revenue YoY | 42.2% | 407.0% |
| Net Profit YoY | 63.8% | -4.7% |
| EPS (diluted) | $1.10 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.2M | $38.3M | ||
| Q3 25 | $50.9M | $32.1M | ||
| Q2 25 | $50.3M | $26.4M | ||
| Q1 25 | $43.5M | $16.5M | ||
| Q4 24 | $33.2M | $7.6M | ||
| Q3 24 | $34.1M | $6.1M | ||
| Q2 24 | $33.3M | — | ||
| Q1 24 | $31.6M | — |
| Q4 25 | $10.8M | $-61.9M | ||
| Q3 25 | $14.9M | $-67.3M | ||
| Q2 25 | $11.6M | $-92.6M | ||
| Q1 25 | $-272.0K | $-129.6M | ||
| Q4 24 | $6.6M | $-59.2M | ||
| Q3 24 | $7.2M | $-85.7M | ||
| Q2 24 | $11.3M | — | ||
| Q1 24 | $6.8M | — |
| Q4 25 | — | 99.0% | ||
| Q3 25 | — | 99.4% | ||
| Q2 25 | — | 99.5% | ||
| Q1 25 | — | 99.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 27.9% | -169.0% | ||
| Q3 25 | 37.2% | -173.5% | ||
| Q2 25 | 29.7% | -269.8% | ||
| Q1 25 | -1.3% | -390.1% | ||
| Q4 24 | 24.8% | -919.0% | ||
| Q3 24 | 27.6% | -1314.3% | ||
| Q2 24 | 42.8% | — | ||
| Q1 24 | 26.9% | — |
| Q4 25 | 22.9% | -161.8% | ||
| Q3 25 | 29.2% | -209.8% | ||
| Q2 25 | 23.2% | -350.3% | ||
| Q1 25 | -0.6% | -784.9% | ||
| Q4 24 | 19.9% | -783.4% | ||
| Q3 24 | 21.1% | -1404.0% | ||
| Q2 24 | 33.9% | — | ||
| Q1 24 | 21.4% | — |
| Q4 25 | $1.10 | $-0.06 | ||
| Q3 25 | $1.42 | $-0.07 | ||
| Q2 25 | $1.11 | $-0.10 | ||
| Q1 25 | $-0.03 | $-0.15 | ||
| Q4 24 | $0.77 | $-0.08 | ||
| Q3 24 | $0.84 | $-0.14 | ||
| Q2 24 | $1.32 | — | ||
| Q1 24 | $0.80 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $65.6M | $242.8M |
| Total DebtLower is stronger | $255.4M | — |
| Stockholders' EquityBook value | $420.0M | $-500.5M |
| Total Assets | $3.2B | $501.9M |
| Debt / EquityLower = less leverage | 0.61× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $65.6M | $242.8M | ||
| Q3 25 | $102.1M | $257.8M | ||
| Q2 25 | $103.1M | $153.7M | ||
| Q1 25 | $123.6M | $61.6M | ||
| Q4 24 | $47.3M | $149.8M | ||
| Q3 24 | $58.1M | $130.4M | ||
| Q2 24 | $86.3M | — | ||
| Q1 24 | $53.1M | — |
| Q4 25 | $255.4M | — | ||
| Q3 25 | $255.4M | — | ||
| Q2 25 | $255.4M | — | ||
| Q1 25 | $255.3M | — | ||
| Q4 24 | $255.3M | — | ||
| Q3 24 | $255.3M | — | ||
| Q2 24 | $255.3M | — | ||
| Q1 24 | $255.3M | — |
| Q4 25 | $420.0M | $-500.5M | ||
| Q3 25 | $408.6M | $-524.3M | ||
| Q2 25 | $395.2M | $-570.7M | ||
| Q1 25 | $386.9M | $-591.4M | ||
| Q4 24 | $303.3M | $-489.1M | ||
| Q3 24 | $306.8M | $-745.1M | ||
| Q2 24 | $289.3M | — | ||
| Q1 24 | $279.9M | — |
| Q4 25 | $3.2B | $501.9M | ||
| Q3 25 | $3.3B | $519.0M | ||
| Q2 25 | $3.3B | $402.1M | ||
| Q1 25 | $3.3B | $303.8M | ||
| Q4 24 | $2.4B | $382.9M | ||
| Q3 24 | $2.4B | $364.6M | ||
| Q2 24 | $2.5B | — | ||
| Q1 24 | $2.4B | — |
| Q4 25 | 0.61× | — | ||
| Q3 25 | 0.62× | — | ||
| Q2 25 | 0.65× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.84× | — | ||
| Q3 24 | 0.83× | — | ||
| Q2 24 | 0.88× | — | ||
| Q1 24 | 0.91× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $53.6M | $-70.4M |
| Free Cash FlowOCF − Capex | $52.6M | $-71.3M |
| FCF MarginFCF / Revenue | 111.4% | -186.2% |
| Capex IntensityCapex / Revenue | 2.3% | 2.4% |
| Cash ConversionOCF / Net Profit | 4.96× | — |
| TTM Free Cash FlowTrailing 4 quarters | $92.2M | $-308.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $53.6M | $-70.4M | ||
| Q3 25 | $23.2M | $-68.9M | ||
| Q2 25 | $17.8M | $-79.7M | ||
| Q1 25 | $-71.0K | $-85.9M | ||
| Q4 24 | $39.8M | $-85.1M | ||
| Q3 24 | $13.6M | $-98.8M | ||
| Q2 24 | $9.7M | — | ||
| Q1 24 | $10.8M | — |
| Q4 25 | $52.6M | $-71.3M | ||
| Q3 25 | $22.8M | $-69.6M | ||
| Q2 25 | $17.6M | $-80.8M | ||
| Q1 25 | $-730.0K | $-87.0M | ||
| Q4 24 | $38.8M | $-87.3M | ||
| Q3 24 | $13.3M | $-101.6M | ||
| Q2 24 | $9.4M | — | ||
| Q1 24 | $10.7M | — |
| Q4 25 | 111.4% | -186.2% | ||
| Q3 25 | 44.7% | -217.2% | ||
| Q2 25 | 35.0% | -305.9% | ||
| Q1 25 | -1.7% | -526.9% | ||
| Q4 24 | 117.0% | -1155.4% | ||
| Q3 24 | 39.1% | -1663.2% | ||
| Q2 24 | 28.3% | — | ||
| Q1 24 | 33.9% | — |
| Q4 25 | 2.3% | 2.4% | ||
| Q3 25 | 0.8% | 2.3% | ||
| Q2 25 | 0.4% | 4.1% | ||
| Q1 25 | 1.5% | 6.8% | ||
| Q4 24 | 2.9% | 28.0% | ||
| Q3 24 | 0.7% | 45.7% | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 0.2% | — |
| Q4 25 | 4.96× | — | ||
| Q3 25 | 1.56× | — | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.03× | — | ||
| Q3 24 | 1.88× | — | ||
| Q2 24 | 0.86× | — | ||
| Q1 24 | 1.60× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
